We developed an immunosensor based on the aggregation of IMBs for one-step detection of pathogens and cancer biomarkers in real samples. IMBs act as the optical readout for assays and serve as the carrier for purification/separation.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: